FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157626001> ?p ?o ?g. }

• W2157626001 endingPage "876" @default.
• W2157626001 startingPage "867" @default.
• W2157626001 abstract "Between August 1989 and November 2003, 33 patients at our center with acquired aplastic anemia underwent bone marrow transplantation (BMT) from HLA-identical sibling donors with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies (MoAb) for conditioning. The median age at BMT was 17 years (range, 4-46 years). Before BMT, 58% were heavily transfused (>50 transfusions), and 42% had previously experienced treatment failure with antithymocyte globulin-based immunosuppressive therapy. Unmanipulated bone marrow was used as the source of stem cells in all patients except 1. Graft-versus-host disease (GVHD) prophylaxis was with cyclosporine alone in 19 (58%) patients; 14 received anti-CD52 MoAb in addition to cyclosporine. The conditioning regimen was well tolerated without significant acute toxicity. Graft failure was seen in 8 patients (primary, n = 4; secondary, n = 4). Of those whose grafts failed, 4 survived long-term (complete autologous recovery, n = 2; rescue with previously stored marrow, n = 1; second allograft, n = 1). The cumulative incidence of graft failure and grade II to IV acute and chronic GVHD was 24%, 14%, and 4%, respectively. None developed extensive chronic GVHD. With a median follow-up of 59 months, the 5-year survival was 81% (95% confidence interval, 68%-96%). No unexpected early or late infectious or noninfectious complications were observed. We conclude that the conditioning regimen containing cyclophosphamide and anti-CD52 MoAb is well tolerated and effective for acquired aplastic anemia with HLA-matched sibling donors. The favorable effect on the incidence and severity of GVHD is noteworthy in this study and warrants further investigation." @default.
• W2157626001 created "2016-06-24" @default.
• W2157626001 creator A5002719979 @default.
• W2157626001 creator A5026724408 @default.
• W2157626001 creator A5029748632 @default.
• W2157626001 creator A5035771451 @default.
• W2157626001 creator A5041803179 @default.
• W2157626001 creator A5054638346 @default.
• W2157626001 creator A5058361291 @default.
• W2157626001 creator A5061689122 @default.
• W2157626001 creator A5067214379 @default.
• W2157626001 creator A5083153761 @default.
• W2157626001 creator A5087494074 @default.
• W2157626001 creator A5089096852 @default.
• W2157626001 date "2004-12-01" @default.
• W2157626001 modified "2023-10-01" @default.
• W2157626001 title "Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia" @default.
• W2157626001 cites W131854666 @default.
• W2157626001 cites W134880196 @default.
• W2157626001 cites W1530764705 @default.
• W2157626001 cites W1571009995 @default.
• W2157626001 cites W196567407 @default.
• W2157626001 cites W1973617793 @default.
• W2157626001 cites W1981956641 @default.
• W2157626001 cites W1983705969 @default.
• W2157626001 cites W1987061419 @default.
• W2157626001 cites W1989919141 @default.
• W2157626001 cites W1990941789 @default.
• W2157626001 cites W1991239009 @default.
• W2157626001 cites W1992546268 @default.
• W2157626001 cites W1998571801 @default.
• W2157626001 cites W2025545136 @default.
• W2157626001 cites W2029076563 @default.
• W2157626001 cites W2049212229 @default.
• W2157626001 cites W2053278212 @default.
• W2157626001 cites W2064796513 @default.
• W2157626001 cites W2069955449 @default.
• W2157626001 cites W2073210769 @default.
• W2157626001 cites W2096944251 @default.
• W2157626001 cites W2107412758 @default.
• W2157626001 cites W2108929825 @default.
• W2157626001 cites W2119591903 @default.
• W2157626001 cites W2133845802 @default.
• W2157626001 cites W2140778701 @default.
• W2157626001 cites W2144022798 @default.
• W2157626001 cites W2158837255 @default.
• W2157626001 cites W2319873259 @default.
• W2157626001 cites W240316314 @default.
• W2157626001 cites W3021273376 @default.
• W2157626001 cites W3117239408 @default.
• W2157626001 cites W4234941390 @default.
• W2157626001 cites W4237946219 @default.
• W2157626001 cites W4255703227 @default.
• W2157626001 cites W42774651 @default.
• W2157626001 cites W4293241248 @default.
• W2157626001 doi "https://doi.org/10.1016/j.bbmt.2004.09.001" @default.
• W2157626001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15570255" @default.
• W2157626001 hasPublicationYear "2004" @default.
• W2157626001 type Work @default.
• W2157626001 sameAs 2157626001 @default.
• W2157626001 citedByCount "48" @default.
• W2157626001 countsByYear W21576260012012 @default.
• W2157626001 countsByYear W21576260012013 @default.
• W2157626001 countsByYear W21576260012014 @default.
• W2157626001 countsByYear W21576260012015 @default.
• W2157626001 countsByYear W21576260012016 @default.
• W2157626001 countsByYear W21576260012017 @default.
• W2157626001 countsByYear W21576260012020 @default.
• W2157626001 countsByYear W21576260012023 @default.
• W2157626001 crossrefType "journal-article" @default.
• W2157626001 hasAuthorship W2157626001A5002719979 @default.
• W2157626001 hasAuthorship W2157626001A5026724408 @default.
• W2157626001 hasAuthorship W2157626001A5029748632 @default.
• W2157626001 hasAuthorship W2157626001A5035771451 @default.
• W2157626001 hasAuthorship W2157626001A5041803179 @default.
• W2157626001 hasAuthorship W2157626001A5054638346 @default.
• W2157626001 hasAuthorship W2157626001A5058361291 @default.
• W2157626001 hasAuthorship W2157626001A5061689122 @default.
• W2157626001 hasAuthorship W2157626001A5067214379 @default.
• W2157626001 hasAuthorship W2157626001A5083153761 @default.
• W2157626001 hasAuthorship W2157626001A5087494074 @default.
• W2157626001 hasAuthorship W2157626001A5089096852 @default.
• W2157626001 hasBestOaLocation W21576260011 @default.
• W2157626001 hasConcept C120665830 @default.
• W2157626001 hasConcept C121332964 @default.
• W2157626001 hasConcept C126322002 @default.
• W2157626001 hasConcept C141071460 @default.
• W2157626001 hasConcept C203014093 @default.
• W2157626001 hasConcept C2776694085 @default.
• W2157626001 hasConcept C2776755627 @default.
• W2157626001 hasConcept C2778384904 @default.
• W2157626001 hasConcept C2779015954 @default.
• W2157626001 hasConcept C2779972918 @default.
• W2157626001 hasConcept C2780007613 @default.
• W2157626001 hasConcept C2781440808 @default.
• W2157626001 hasConcept C2911091166 @default.
• W2157626001 hasConcept C61511704 @default.
• W2157626001 hasConcept C71924100 @default.

• next